To include your compound in the COVID-19 Resource Center, submit it here.

BTA585: Phase IIa suspended enrollment

Aviragen voluntarily suspended enrollment in a double-blind, placebo-controlled, U.K. Phase IIa trial of oral BTA585 after 1

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE